Home Healthcare Biotechnology Preterm Birth and PROM Testing Market

Preterm Birth and PROM Testing Market Size, Share & Trends Analysis Report By Test Type (Pelvic Examination, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR5107DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Preterm Birth and PROM Testing Market, By Test Type 2022-2034 (USD MILLION/ Units)
    1. Pelvic Examination
    2. Ultrasound
    3. Biochemical Markers
    4. Uterine Monitoring
    5. Nitazine Test, Ferning Test
    6. Pooling
    7. PAMG-1 Immunoassay
    8. IGFBP Test
    9. Fetal Fibronectin (fFN)
    10. Others
  2. Regional Preterm Birth and PROM Testing Market
    1. North America
      1. North America Preterm Birth and PROM Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      2. U.S.
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      3. Canada
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
    2. Europe
      1. Europe Preterm Birth and PROM Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      2. U.K.
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      3. Germany
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      4. France
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      5. Spain
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      6. Italy
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      7. Russia
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      8. Nordic
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      9. Benelux
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      10. Rest of Europe
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
    3. APAC
      1. APAC Preterm Birth and PROM Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      2. China
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      3. Korea
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      4. Japan
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      5. India
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      6. Australia
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      7. Singapore
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      8. Taiwan
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      9. South East Asia
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      10. Rest of Asia-Pacific
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Preterm Birth and PROM Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      2. UAE
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      3. Turkey
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      4. Saudi Arabia
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      5. South Africa
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      6. Egypt
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      7. Nigeria
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      8. Rest of MEA
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
    5. LATAM
      1. LATAM Preterm Birth and PROM Testing Market By Test Type 2022-2034 (USD MILLION/ Units)
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      2. Brazil
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      3. Mexico
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      4. Argentina
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      5. Chile
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      6. Colombia
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
      7. Rest of LATAM
        1. Pelvic Examination
        2. Ultrasound
        3. Biochemical Markers
        4. Uterine Monitoring
        5. Nitazine Test, Ferning Test
        6. Pooling
        7. PAMG-1 Immunoassay
        8. IGFBP Test
        9. Fetal Fibronectin (fFN)
        10. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.